| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |